WT1 TCR-transduced T cells: Phase I/II ongoing

A DSMB recommended continuation to the second dose cohort of an open-label, U.K. Phase I/II trial evaluating WT1 TCR-transduced T cells in up to 18 patients. The DSMB reviewed data from the first coho...